Scientists have developed ThermoCas9, a gene-editing enzyme that can distinguish cancer cells from healthy ones by reading DNA methylation patterns, potentially reducing off-target damage in CRISPR ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果